La stratégie thérapeutique anti-VEGF améliore le pronostic visuel de la dégénérescence maculaire liée à l'âge exsudative [Intravitreal anti-VEGF injections improve the visual prognosis of wet age related macular degeneration].

Details

Serval ID
serval:BIB_A800D8F61C38
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
La stratégie thérapeutique anti-VEGF améliore le pronostic visuel de la dégénérescence maculaire liée à l'âge exsudative [Intravitreal anti-VEGF injections improve the visual prognosis of wet age related macular degeneration].
Journal
Revue Médicale Suisse
Author(s)
Ambresin A., Mantel I.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
2007
Volume
3
Number
94
Pages
137-141
Language
french
Notes
Publication types: English Abstract ; Journal Article ; Review
Abstract
Age related macular degeneration (AMD) is an ocular disease with high prevalence among elderly persons. Two different forms exist: dry AMD, usually slowly progressive, and neovascular AMD (wet form) more aggressive. Photodynamic therapy is used to treat the wet form and anti VEGF treatments recently became available and offer a real change in the prognostic of wet AMD. Two products are registered and used in Switzerland (Macugen and Lucentis), a third "off labels product", Avastin is also currently used in clinical practice. Nevertheless, both the duration of treatment and the number of injection requested to stabilise the disease were not defined in the studies. Ongoing studies are mainly evaluating combined treatments and long acting form of the drug.
Keywords
Antibodies, Monoclonal/therapeutic use, Humans, Injections, Macular Degeneration/drug therapy, Prognosis, Vascular Endothelial Growth Factors/antagonists & inhibitors, Vitreous Body
Pubmed
Create date
06/09/2011 10:41
Last modification date
20/08/2019 15:12
Usage data